Literature DB >> 16997719

Particulate delivery systems for animal vaccines.

Jean-Pierre Y Scheerlinck1, Deanne L V Greenwood.   

Abstract

The requirements for veterinary vaccines are different to those of human vaccines. Indeed, while more side effects can be tolerated in animals than in humans; there are stricter requirements in terms of cost, ease of delivery (including to wildlife), and a need to develop vaccines in species for which relatively little is known in terms of molecular immunology. By their nature particulate vaccine delivery systems are well suited to address these challenges. Here, we review particulate vaccine delivery systems, ranging from cm-sized long-distance ballistic devices to nano-bead technology for veterinary species and wildlife.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16997719     DOI: 10.1016/j.ymeth.2006.05.023

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  11 in total

1.  Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis.

Authors:  Natalie A Parlane; Katrin Grage; Jun Mifune; Randall J Basaraba; D Neil Wedlock; Bernd H A Rehm; Bryce M Buddle
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

Review 2.  Current status of veterinary vaccines.

Authors:  Els N T Meeusen; John Walker; Andrew Peters; Paul-Pierre Pastoret; Gregers Jungersen
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

3.  Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System.

Authors:  G Martínez-Donato; B Piniella; D Aguilar; S Olivera; A Pérez; Y Castañedo; L Alvarez-Lajonchere; S Dueñas-Carrera; J W Lee; N Burr; M Gonzalez-Miro; B H A Rehm
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

4.  Ultrasonic synthetic technique to manufacture a pHEMA nanopolymeric-based vaccine against the H6N2 avian influenza virus: a preliminary investigation.

Authors:  Gérrard Eddy Jai Poinern; Xuan Thi Le; Songhua Shan; Trevor Ellis; Stan Fenwick; John Edwards; Derek Fawcett
Journal:  Int J Nanomedicine       Date:  2011-09-28

Review 5.  Nanovaccines: recent developments in vaccination.

Authors:  Tarala D Nandedkar
Journal:  J Biosci       Date:  2009-12       Impact factor: 2.795

6.  Evaluation of protective efficacy using a nonstructural protein NS1 in DNA vaccine-loaded microspheres against dengue 2 virus.

Authors:  Shih-shiung Huang; I-Hsun Li; Po-da Hong; Ming-kung Yeh
Journal:  Int J Nanomedicine       Date:  2013-08-19

Review 7.  Virus-like particles: the new frontier of vaccines for animal viral infections.

Authors:  Elisa Crisci; Juan Bárcena; María Montoya
Journal:  Vet Immunol Immunopathol       Date:  2012-06-01       Impact factor: 2.046

8.  Formulation and delivery of vaccines: Ongoing challenges for animal management.

Authors:  Sameer Sharma; Lyn A Hinds
Journal:  J Pharm Bioallied Sci       Date:  2012-10

9.  Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens.

Authors:  Victor Riitho; Adam A Walters; Satyanarayana Somavarapu; Benjamin Lamp; Till Rümenapf; Thomas Krey; Felix A Rey; Ernesto Oviedo-Orta; Graham R Stewart; Nicolas Locker; Falko Steinbach; Simon P Graham
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

Review 10.  Virus-like particle-based vaccines for animal viral infections.

Authors:  Elisa Crisci; Juan Bárcena; María Montoya
Journal:  Inmunologia       Date:  2012-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.